Brief: Morgan Stanley’S Long Position In WuXi Biologics (Cayman) Decreases To 2.11% On Jan 20 From 5.58%, HKEX Shows
Jan 23 (Reuters) - HKEX: MORGAN STANLEY’S LONG POSITION IN WUXI BIOLOGICS (CAYMAN) DECREASES TO 2.11% ON JAN 20 FROM 5.58% Further company coverage: 2269.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln